Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial

By sjmartinez • June 28, 2024

Dehghani P, Srivatsav V, Vardeny O, Grewal J, Opotowsky AR, Muhll IV, Keir M, Ducas R, Singh J, Kim K, Joseph J, Aboulhosn J, Havighurst T, Hegde SM, Bhatt DL, Solomon S, Farkouh M, Goodman SG, Moe TG, Udell JA. Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial. JACC Adv. 2024 Mar 14;3(4):100897. doi: 10.1016/j.jacadv.2024.100897. PMID: 38939662; PMCID: PMC11198655.

Tags: adult congenital, Cardiology/Epi, Heart disease, Influenza, Publications, Vaccination

Novel Virtual Reality Intervention for Stress Reduction Among Patients With or at Risk for Cardiovascular Disease: Mixed Methods Pilot Study

Makaroff KE, Van C, Grospe V, Edmunds L, Calfon-Press MA, Watson KE, Horwich T. Novel Virtual Reality Intervention for Stress Reduction Among Patients With or[...]

Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve replacement

Liu Z, Aguayo E, Porter G, Ali K, Zinoviev R, Benharash P. Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve[...]

Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial

Revaiah PC, Serruys PW, Onuma Y, Andreini D, Budoff MJ, Sharif F, Chernofsky A, Vikarunnessa S, Wiethoff AJ, Yates D, Achouba A. Design and rationale[...]